The largest database of trusted experimental protocols

Pdonr221

Manufactured by Thermo Fisher Scientific
Sourced in United States, Germany

The PDONR221 is a high-performance laboratory equipment designed for precise and reliable measurements. It features advanced technology to ensure accurate and reproducible results. The core function of this product is to perform specific laboratory tasks, but a detailed description cannot be provided while maintaining an unbiased and factual approach.

Automatically generated - may contain errors

190 protocols using pdonr221

1

Cloning and Expression of Macrodomain Proteins

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human full length MacroD1 was amplified from a human HeLa cDNA library and cloned into pDONR221 (Thermo Fisher) entry vector and a N-terminal truncation mutant was generated the same way by excluding the first 77 amino acids using a different N-terminal primer. SCO6450 (UniProt: Q9ZBG3) was cloned from total Streptomyces coelicolor DNA. For transient transfection in human cells, full-length and truncated MacroD1 pDONR221 vectors were recombined using the Gateway LR reaction (Thermo Fisher) into the pDEST47 destination vector for the expression of C-terminal GFP fused proteins in human cell lines. PARP1 EQ was expressed in pET28 vector and was purified as previously described (Sharifi et al., 2013 (link)). DarT was expressed in pBAD vector, transformed into BL21 strains, induced with arabinose and purified using TALON affinity resin (Clontech) as previously described (Jankevicius et al., 2016 (link)). Macrodomain proteins were expressed in pDEST17 or pET15b and purified as previously described (Chen et al., 2011 (link)).
+ Open protocol
+ Expand
2

Construct Development for BrWRI1.2 Promoter Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the BrWRI1.2 promoter, a 1500 bp long fragment upstream of the BrWRI1.2 (Bra003178) coding region was amplified from B. rapa R-0-18 genomic DNA. The fragment was cloned via a gateway BP reaction into pDONR221 (Thermo Fisher Scientific, Waltham, MA, USA) before being shuffled via a gateway LR reaction (Thermo Fisher Scientific, Waltham, MA, USA) into the binary vector pMDC162 [45 (link)] to allow proBrWRI1.2-controlled GUS expression. In addition, the same promoter was cloned into the gateway-compatible, binary vector pMDC43 via HindIII/KpnI sites, replacing its 35S promoter, to generate a proWRI1.2-pMDC43 vector. For the U:PEST construct, a PEST-containing C-terminal region from BrRAP2.4-1 (Bra003659) was amplified from the corresponding cDNA and fused to a UBQ:eK element as described in [31 (link)]. The corresponding U:PEST was first cloned into pDONR221 before being shuffled into proWRI1.2-pMDC43 using gateway BP and LR reactions (Thermo Fisher Scientific, Waltham, MA, USA), respectively. For a full sequence of the UBQ:eK:PEST see [31 (link)]. All primers used are listed in Table S2 All constructs were verified before usage by sequencing for correct translational frame and absence of PCR-generated mutations.
+ Open protocol
+ Expand
3

Gateway Cloning of Drosophila Genes

Check if the same lab product or an alternative is used in the 5 most similar protocols
To produce each construct, the coding sequence of each gene was amplified from whole larva cDNA using the PrimeScript RT-PCR Kit (cat #RR014-A; Takara). The amplified sequence was then purified through gel extraction (cat #D2111-03; Magen HiPure Gel Pure DNA Mini kit). Flanking att sequences were added through another round of PCR (cat #R011; Takara) and purified. The resulting products were then recombined into pDONR221 (cat #12536017; Thermo Fisher Scientific) through a Gateway BP reaction with Gateway BP Clonase II Enzyme Mix (cat #11789020; Thermo Fisher Scientific) to produce pDONR221-p24 entry clones. From there, p24 sequences were transferred into modified Gateway destination vector pTSGW (UASt-Signal peptide of Tango1-GFP-Gateway cassette) (Yang et al., 2021 (link)) through Gateway LR recombination using LR Clonase II Plus enzyme (cat #12538120; Thermo Fisher Scientific) to obtain the desired plasmids.
Primers used were as follows: Eclair-F, Eclair-R, att-Eclair-F, and att-Eclair-R; CHOp24-F, CHOp24-R, att-CHOp24-F, and att-CHOp24-R; Logjam-F, Logjam-R, att-Logjam-F, and att-Logjam-R; and Baiser-F, Baiser-R, att-Baiser-F, and att-Baiser-R. Primer sequences are listed in Table S2.
+ Open protocol
+ Expand
4

UBA1 Variant Cloning and Mutagenesis

Check if the same lab product or an alternative is used in the 5 most similar protocols
UBA1 complementary DNA (NM_003334.4) was obtained from GenScript (CloneID OHu24932) in pcDNA3.1, PCR amplified, and subcloned into pDONR221 (ThermoFisher Scientific, 12536017) using Gateway BP Clonase II (Thermo Fisher Scientific, 11789020). pDONR221-UBA1 was modified using NEB Q5 Site-Directed Mutagenesis Kit (New England Biolabs, E0554S) to generate the following pDONR221-UBA1 constructs: Δ1-40 (UBA1b) and Δ1-40/C632A (catalytically inactive UBA1b).20 (link) Lentiviral expression constructs for UBA1 variants and Renilla lucerifase were generated via Gateway LR Clonase II (Thermo Fisher Scientific, 11791020) reaction between each pDONR221 plasmid and lentiviral destination plasmid pLEX307 (Addgene, 41392). All pDONR221 and pLEX307 constructs were confirmed by Sanger sequencing (Genewiz) and alignment using Benchling Biology Software (2021-2023; https://benchling.com).
+ Open protocol
+ Expand
5

Cloning Cbx-KRAB Domain Fusions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Genes encoding Cbx-KRAB domain fusions were synthesized as gene fragments (Integrated DNA Technologies) and cloned with the Gateway BP Clonase II system (Thermo Fisher, 11789020) into the Gateway Entry vector pDONR221 (Thermo Fisher) according to the manufacturer’s protocols. Cbx-KRAB domain fusions cloned into pDONR221 were then transferred, via Gateway LR Clonase II system (Thermo Fisher, 11791020), into the pLX303-dCas9 vector38 (link) (a kind gift of Dr. Taipale, University of Toronto). The pLX303-dCas9 vector encoded a Streptococcus pyogenes dCas9 with two C-terminal and one N-terminal SV40 nuclear localization signals. See Supplementary Dataset 5 for sequences of all dCas9-repressors used in this study.
+ Open protocol
+ Expand
6

Lentiviral Expression System Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
All recombinant DNA work was carried out under approval of the Environmental Health Safety Division of UNC-Chapel Hill. Lentiviral expression plasmids were created by E. Campeau and obtained from Addgene: pLenti CMV-GFP-DEST (736-1, Addgene plasmid 19732), pLenti CMV/TO GFP-Zeo DEST (719-1, Addgene 17431). Packaging plasmids psPax2 and pMD2.6 were created by Didier Trono (Addgene plasmids 12259 and 12260). Mouse ORF-eome constructs were acquired from the ATCC I.M.A.G.E Consortium, then cloned into pDONR 221 (Invitrogen) Gateway donor vectors using Clonase BP (Invitrogen). Cloned pDONR 221 vectors were sub-cloned into lentiviral expression vectors by Clonase LR reaction (Invitrogen). Lentiviral backbones were transfected with 1.5 μg packaging plasmids psPAX2 and pMDG2 with 15 μl Lipofectamine 2000 in 6-well plates into HEK293T cells. Viral particles were harvested at 24 and 48 hours post transfection. Viral particles were used to infect target cells with 10 μg/mL Polybrene in antibiotic-free media.
+ Open protocol
+ Expand
7

Cloning and Expression of Bag101 and Bag102 in S. pombe

Check if the same lab product or an alternative is used in the 5 most similar protocols
To generate Bag101 (SPBC16G5.11c) constructs, FL (full length), BAG domain (amino acids 78–190) and UBL domain (1–77) cDNAs were amplified from S. pombe genomic DNA and inserted into pDONR221 (Invitrogen) and pGEX-KG (GE Healthcare). Full length bag102+ (SPBC530.03c), ΔTM (31–206), BAG (122–206) and UBL (31–121) cDNAs were also inserted into the pDONR221 and pGEX-KG vectors. For expression in S. pombe, the inserts from the pDONR221 vectors were transferred to the pDUAL vector system [54] (link) using Gateway cloning technology (Invitrogen). Both ubp3 variants were cloned via XhoI/NotI into the pJR2-3XL vector with the nmt1+ promoter [55] (link). The HA-tagged Spc7-23 construct was obtained by QuikChange site directed mutagenesis (Stratagene) on pJR-XU41 plasmid encoding Spc7-3HA. The expression construct for 6His-ubiquitin has been described before [56] (link). The expression construct for San1 was kindly provided by Dr Makoto Kawamukai [57] (link).
+ Open protocol
+ Expand
8

Lentiviral Expression System Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
All recombinant DNA work was carried out under approval of the Environmental Health Safety Division of UNC-Chapel Hill. Lentiviral expression plasmids were created by E. Campeau and obtained from Addgene: pLenti CMV-GFP-DEST (736-1, Addgene plasmid 19732), pLenti CMV/TO GFP-Zeo DEST (719-1, Addgene 17431). Packaging plasmids psPax2 and pMD2.6 were created by Didier Trono (Addgene plasmids 12259 and 12260). Mouse ORF-eome constructs were acquired from the ATCC I.M.A.G.E Consortium, then cloned into pDONR 221 (Invitrogen) Gateway donor vectors using Clonase BP (Invitrogen). Cloned pDONR 221 vectors were sub-cloned into lentiviral expression vectors by Clonase LR reaction (Invitrogen). Lentiviral backbones were transfected with 1.5 μg packaging plasmids psPAX2 and pMDG2 with 15 μl Lipofectamine 2000 in 6-well plates into HEK293T cells. Viral particles were harvested at 24 and 48 hours post transfection. Viral particles were used to infect target cells with 10 μg/mL Polybrene in antibiotic-free media.
+ Open protocol
+ Expand
9

Construction of Bordetella bronchiseptica Deletion Mutant

Check if the same lab product or an alternative is used in the 5 most similar protocols
pDONR221 (Invitrogen) and pABB-CRS2 [20 (link)] were used as cloning and positive suicide vectors, respectively. The construction of a deletion mutant using pABB-CRS2 has been described previously [10 (link)]. A 7.1-kbp DNA fragment containing the cyaA gene and its flanking region was amplified by PCR with the primers B1-cyaA and B2-cyaA using B. bronchiseptica S798 genomic DNA as a template. The resulting PCR product was cloned into pDONR221 using the adaptor PCR method (Gateway cloning system, Invitrogen) to obtain pDONR-cyaA. For the deletion of cyaA in pDONR-cyaA, inverse PCR was then carried out with the primers R1-cyaA and R2-cyaA using circular pDONR-cyaA as a template. The resulting PCR products were digested with HindIII and self-ligated to obtain pDONRcyaA, which contained a HindIII site in addition to a 4959-bp deletion including the start codon of cyaA. The cyaA fragment with internal deletion was transferred to pABB-CRS2 to obtain pABB-CRS2-ΔcyaA using the Gateway cloning system. pABB-CRS2-ΔcyaA was then introduced into E. coli SM10λpir and was transconjugated into B. bronchiseptica S798 ΔbteA, which is unable to induce necrosis to mammalian cells as described previously [10 (link)]. The resulting mutant strain was designated S798 ΔbteA ΔcyaA.
+ Open protocol
+ Expand
10

Constructing oxyR Gene Deletion Mutant

Check if the same lab product or an alternative is used in the 5 most similar protocols
Complete deletion of the oxyR gene was carried out as previously described [57] (link). All primer sequences are described in Table S2. Briefly, a first round of three PCR reactions was performed in which the 5′ and 3′ flanking regions of oxyR, as well as a Gm resistance cassette were amplified from plasmid pPS856 [58] (link) using four gene-specific primers (Oxy-UpF-GWL, Oxy-UpR-Gm, Oxy-DnF-Gm and Oxy-DnR-GWR) and the common Gm-specific primers (Gm-F and Gm-R). This generated three fragments with partial overlaps either to each other or the attB1 and attB2 recombination sites. The purified fragments were then assembled in vitro by overlap extension during the second round PCR using the common primers GW-attB1 and GW-attB2. This resulted in an oxyR-deletion-mutant PCR fragment which was subsequently cloned into pDONR221 (Invitrogen) via the BP clonase reaction to create pDONR221-oxyR::Gm. This construct served as the substrate for LR clonase-mediated recombination into the destination vector pEX18ApGW. The resulting suicide vector pEX18ApGW-oxyR::Gm was then transferred to P. aeruginosa and the plasmid-borne oxyR-deletion mutation was exchanged with the chromosome via homologous recombination to generate the chromosomal deletion mutant.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!